Dr. Teresa Ramon y Cajal is Consultant in Familial Cancer at the Medical Oncology Department, Hospital Sant Pau, Barcelona, the oldest institution involved in Cancer Genetics in Spain since 1995. She has been the leader of the Familial Cancer clinical group since 2005. The Familial Cancer clinic attends an average of 1600 visits per year, 600 of which are first consultations at the Medical Oncology Service. Apart from her responsibility in the clinical group, she takes personal care of the post-test visit and the cancer screening visits for all cancer susceptibility syndromes and participates as an expert in Hereditary Cancer at multidisciplinary committees for breast and colorectal cancers. 

Along with Sant Pau Genetics Service she collaborates in several research studies regarding hereditary cancer in Cataluña, Spain (SEOM) and the Royal Marsden or the Women's College Research Institute in Toronto for two ongoing international multicenter prospective observational studies. Before then, she collaborated with Dr Benitez's group at CNIO and Dra. Marina Pollan at the ISCIII.  She has been awarded with a research SEOM grant in 2020 involving  the clinical utility of the polygenic risk score in CHEK2 families at the Netherlands Cancer Institute.

She is an active member of the Epidemiology and Breast Cancer Prevention Group of the Spanish Group for Research in Breast Cancer (GEICAM), the Spanish Group in Hereditary Cancer of the Medical Oncology Spanish Society (SEOM), the European Society of Medical Oncology (ESMO) and the Spanish Society in Human Genetics (AEGH). She is currently coordinating the Hereditary Breast Cancer annual meeting SEO-GEICAM-SOLTI, the most important educational event on that field. 

The main areas in which Dr. Ramon y Cajal focuses her interest are Genetic Assessment in Hereditary Cancer and Prevention and Breast & Endocrine cancer. Additionally, Dr. Ramon y Cajal is involved in phase II to IV clinical trials in Breast Cancer at Hospital Sant Pau.

Dr Ramon y Cajal received her degree in Medicine and Surgery from the Universidad Autónoma de Madrid in 1994. She specialized in Medical Oncology at Clinica Universitaria de Navarra, completed her training in 2000 and PhD in Hereditary Cancer in 2017. She spent five months at the Memorial Sloan Kettering Cancer Center, NYC, further specializing in Cancer Genetics. She was also Associate Professor at the Universidad Autonoma de Barcelona from 2008 to 2020.

Dr Ramon y Cajal has co-authored more than 80 publications and congress presentations in the most prestigious national scientific meetings. 

She has lectured at the SEOM meeting for the last 5 years on the hereditary breast cancer field and communicated her own group research studies.